Developing therapies, delivering quality of life.
Personalized RNA therapies that act undruggable targets, creating a new era of precision medicine.
Mirscience Therapeutics develops therapies for diseases associated with longevity.
Using the Mir-Discovery platform, we have developed microRNA molecules that act on challenging targets, expanding treatments options for unmet medical needs that affect patients’ quality of life.
All Your Dental Needs at One Place
Our mission is to support patients in their independence and quality of life.
Diseases associated with longevity
Healthy aging is an ongoing process of taking advantage of opportunities to keep and improve physical and mental health, autonomy, and well-being throughout a patient’s entire life. Among several factors that avoid healthy aging and impact quality of life, muscular and metabolic diseases call attention as the main factors for decreasing patients’ well-being and autonomy. In addition to that, other effects are the increase in health-related costs and mortality rates.
Using our drug discovery platform,
we identify main therapeutic targets linked to each disease, and develop oligonucleotides based on microRNAs that act on these targets, leading to establishing customized therapies for each disease.
Our molecules for muscular atrophy diseases. Therapies focused on muscle tissue diseases
Out first molecule, MT-29, has regenerative and hipertrofic effect on muscle mass which is a potential therapy for disease that cause atrophy and muscle frailty, such as, sarcopenia, caquexia induced by cancer, and muscle atrophy related to ortopedic lesion.